T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.84B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.1B |
| 4 |
Bank of America
BAC
|
+$860M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$618M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.19B |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 3 |
JPMorgan Chase
JPM
|
+$1.29B |
| 4 |
Booking.com
BKNG
|
+$1.06B |
| 5 |
Merck
MRK
|
+$757M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Healthcare | 18.48% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 13.47% |
| 5 | Communication Services | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBT
876
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $50.1M | 0.01% |
4,942,345
+588,378
| +14% | +$5.44M |
|
877
Q2 Holdings
QTWO
$3.44B
| $50M | 0.01% |
721,656
-418,558
| -37% | -$26.1M |
|
878
Viatris
VTRS
$21B
| $50M | 0.01% |
1,763,535
-564,200
| -24% | -$16.5M |
|
|
TVRD
879
Tvardi Therapeutics
TVRD
$17.7M
| $49.7M | 0.01% |
70,378
+3,281
| +5% | +$1.96M |
|
|
PCH
880
DELISTED
PotlatchDeltic
PCH
| $49.6M | 0.01% |
1,311,668
-16,481
| -1% | -$588K |
|
881
Qualys
QLYS
$6.01B
| $49.5M | 0.01% |
598,677
+396
| +0.1% | +$33K |
|
882
LyondellBasell Industries
LYB
$18.8B
| $49.1M | 0.01% |
584,553
+13,450
| +2% | +$1.16M |
|
883
Goosehead Insurance
GSHD
$1.06B
| $49.1M | 0.01% |
1,760,111
-206,523
| -11% | -$5.91M |
|
|
B
884
DELISTED
Barnes Group Inc.
B
| $48.9M | 0.01% |
951,405
+17,231
| +2% | +$981K |
|
885
Consolidated Edison
ED
$38B
| $48.9M | 0.01% |
576,252
+46,825
| +9% | +$3.74M |
|
886
Cummins
CMI
$71.3B
| $48.6M | 0.01% |
308,168
+13,500
| +5% | +$2.03M |
|
887
Woodward
WWD
$19.2B
| $48.6M | 0.01% |
512,428
+38,965
| +8% | +$3.45M |
|
888
Advanced Micro Devices
AMD
$992B
| $48.6M | 0.01% |
1,903,262
+59,507
| +3% | +$1.35M |
|
889
Trane Technologies
TT
$99.5B
| $48.5M | 0.01% |
449,418
+4,100
| +0.9% | +$415K |
|
890
Bio-Rad Laboratories Class A
BIO
$10.1B
| $48.3M | 0.01% |
158,001
-1,886
| -1% | -$509K |
|
891
Team
TISI
$130M
| $48M | 0.01% |
274,275
+2,760
| +1% | +$437K |
|
892
CMS Energy
CMS
$19.6B
| $47.8M | 0.01% |
860,834
-278,149
| -24% | -$14.7M |
|
|
HAYN
893
DELISTED
Haynes International, Inc.
HAYN
| $47.7M | 0.01% |
1,452,246
+7,930
| +0.5% | +$256K |
|
894
NetEase
NTES
$77.5B
| $47.4M | 0.01% |
982,190
-304,135
| -24% | -$14.5M |
|
895
Brady Corp
BRC
$3.94B
| $47.4M | 0.01% |
1,021,186
-123,459
| -11% | -$5.67M |
|
896
ACI Worldwide
ACIW
$4.95B
| $47.4M | 0.01% |
1,441,337
+268,388
| +23% | +$8.18M |
|
|
RAVN
897
DELISTED
Raven Industries Inc
RAVN
| $47.2M | 0.01% |
1,229,195
-87,004
| -7% | -$3.3M |
|
|
WBC
898
DELISTED
WABCO HOLDINGS INC.
WBC
| $47.2M | 0.01% |
357,730
-1,124,275
| -76% | -$139M |
|
899
Henry Schein
HSIC
$9.58B
| $47.1M | 0.01% |
784,400
-521,970
| -40% | -$31.5M |
|
900
Brookfield
BN
$81B
| $47M | 0.01% |
2,826,102
+1,758,625
| +165% | +$27.4M |
|
Similar funds
T. Rowe Price Associates's Q1 2019 Portfolio in Review
As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q1 2019 filing shows 56 new, 1,633 increased, 713 reduced and 86 closed positions. Its largest new stake was Fox Class B: 11,707,204 shares worth $420M. The largest sale was Tesla, an estimated $2.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
- T. Rowe Price Associates's biggest Q1 2019 reduction was Tesla, cutting an estimated $2.19B.
- T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
- T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
- T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.